Cargando…

Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies

SIMPLE SUMMARY: Despite the adoption of aggressive, multimodal treatment schedules, the cure rate of high-grade osteosarcoma (HGOS) has not significantly improved in the last 30 years. The most relevant problem preventing improvement in HGOS prognosis is drug resistance. Therefore, validated novel b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hattinger, Claudia Maria, Patrizio, Maria Pia, Fantoni, Leonardo, Casotti, Chiara, Riganti, Chiara, Serra, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228414/ https://www.ncbi.nlm.nih.gov/pubmed/34207685 http://dx.doi.org/10.3390/cancers13122878

Ejemplares similares

Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma
por: Hattinger, Claudia Maria, et al.
Publicado: (2023)

Impact of ABC Transporters in Osteosarcoma and Ewing’s Sarcoma: Which Are Involved in Chemoresistance and Which Are Not?
por: Serra, Massimo, et al.
Publicado: (2021)

Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing
por: Hattinger, Claudia Maria, et al.
Publicado: (2022)

Pharmacogenomics and Pharmacogenetics in Osteosarcoma: Translational Studies and Clinical Impact
por: Hattinger, Claudia Maria, et al.
Publicado: (2020)

Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments
por: Fanelli, Marilù, et al.
Publicado: (2020)

ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma
por: Belisario, Dimas Carolina, et al.
Publicado: (2020)

Small Nucleolar RNAs Determine Resistance to Doxorubicin in Human Osteosarcoma
por: Godel, Martina, et al.
Publicado: (2020)

Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells
por: Vella, Serena, et al.
Publicado: (2016)

Genomics and Therapeutic Vulnerabilities of Primary Bone Tumors
por: Scotlandi, Katia, et al.
Publicado: (2020)

Editorial: Novel therapeutic approaches to target drug resistant tumors
por: Riganti, Chiara, et al.
Publicado: (2023)

Preclinical validation of Aurora kinases-targeting drugs in osteosarcoma
por: Tavanti, E, et al.
Publicado: (2013)

Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy
por: Pasello, Michela, et al.
Publicado: (2011)

Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma
por: Hattinger, Claudia M., et al.
Publicado: (2016)

New Strategies to Overcome Resistance to Chemotherapy and Immune System in Cancer
por: Riganti, Chiara, et al.
Publicado: (2019)

Overcoming drug resistance in glioblastoma: new options in sight?
por: Kopecka, Joanna, et al.
Publicado: (2021)

Editorial: Multidrug Resistance in Cancer: Pharmacological Strategies from Basic Research to Clinical Issues
por: Riganti, Chiara, et al.
Publicado: (2015)

Drug resistance‐related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies
por: Chen, Ruiling, et al.
Publicado: (2019)

Novel molecular insights and new therapeutic strategies in osteosarcoma
por: Otoukesh, Babak, et al.
Publicado: (2018)

Inhibition of the mevalonate pathway to override chemoresistance and promote the immunogenic demise of cancer cells: Killing two birds with one stone
por: Riganti, Chiara, et al.
Publicado: (2013)

Special Issue: “New Diagnostic and Therapeutic Tools against Multidrug-Resistant Tumors (STRATAGEM Special Issue, EU-COST CA17104)”
por: Vasconcelos, M. Helena, et al.
Publicado: (2022)

Searching the Link for Better Therapeutic Combination: The Case of Tumor Cells Migration Pattern and Modality of Immunosuppression Induction at the Metastatic Site
por: Delma, Mohamed Islam, et al.
Publicado: (2020)

Identification of Biomarkers for Osteosarcoma Based on Integration Strategy
por: Bao, Junjie, et al.
Publicado: (2020)

Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
por: Ando, Kosei, et al.
Publicado: (2013)

Molecular pathogenesis and therapeutic strategies of human osteosarcoma
por: Denduluri, Sahitya K, et al.
Publicado: (2016)

Macrophage Repolarization as a Therapeutic Strategy for Osteosarcoma
por: Anand, Namrata, et al.
Publicado: (2023)

Functionalized Keratin as Nanotechnology-Based Drug Delivery System for the Pharmacological Treatment of Osteosarcoma
por: Martella, Elisa, et al.
Publicado: (2018)

T‐LAK cell‐originated protein kinase (TOPK): an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Thanindratarn, Pichaya, et al.
Publicado: (2021)

Cyclin-dependent kinase 7 (CDK7) is an emerging prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Hangzhan, et al.
Publicado: (2021)

Sound-based assembly of a microcapillary network in a saturn-like tumor model for drug testing
por: Di Marzio, Nicola, et al.
Publicado: (2022)

Emerging Therapeutic Strategies to Overcome Drug Resistance in Multiple Myeloma
por: Davis, Lorraine N., et al.
Publicado: (2021)

Emerging Biomarkers and Therapeutic Strategies for Refractory Bullous Pemphigoid
por: Zhou, Tong, et al.
Publicado: (2021)

sCLU as prognostic biomarker and therapeutic target in osteosarcoma
por: Ma, Jinfeng, et al.
Publicado: (2019)

ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells
por: Riganti, Chiara, et al.
Publicado: (2018)

Nanosized drug delivery strategies in osteosarcoma chemotherapy
por: Chen, Chenglong, et al.
Publicado: (2023)

Review of therapeutic strategies for osteosarcoma, chondrosarcoma, and Ewing’s sarcoma
por: Dai, Xing, et al.
Publicado: (2011)

Plant-Derived Trans-β-Caryophyllene Boosts Glucose Metabolism and ATP Synthesis in Skeletal Muscle Cells through Cannabinoid Type 2 Receptor Stimulation
por: Geddo, Federica, et al.
Publicado: (2021)

Targeted Self-Emulsifying Drug Delivery Systems to Restore Docetaxel Sensitivity in Resistant Tumors
por: Campani, Virginia, et al.
Publicado: (2022)

Myc is a prognostic biomarker and potential therapeutic target in osteosarcoma
por: Feng, Wenlong, et al.
Publicado: (2020)

Doxorubicin-Loaded Lipid Nanoparticles Coated with Calcium Phosphate as a Potential Tool in Human and Canine Osteosarcoma Therapy
por: Chirio, Daniela, et al.
Publicado: (2022)

Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications
por: Zhu, Tianyi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eccqhai5pa9itpt1k62qg3oqjv